Regulation der Expression von Scavenger Receptor BI (SR-BI) und des bidirektionalen Cholesterolflux durch den Cholesterol- und Vitamin-E-Gehalt in HepG2-Zellen und High Density LipoproteinenPayman Barikbin 1.61.171.2891.310112.123.133.13.1.13.1.23.2143.33.3.13.3.23.3.33.3.43.3.5153.3.6163.3.7173.3.8183.3.9193.3.10203.3.1121223.3.124.234.12425588#8154.226445#3032728586#7274.32930588#81531567#54832576#6825.335.134355.236375.338396.4041 7. LITERATUR4257Abkürzungen Danksagung58 Lebenslauf5960Eidesstattliche ErklärungdeInhaltsverzeichnisHilfe 7. LITERATUR [1] Tappel, A.L. (1962): Vitamin E as the biological lipid antioxidant, Vit.Horm. (20), Seite 493-510. [2] Burton, G.W.; Joyce, A. und Ingold, K.U. (1983): Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes?, Arch Biochem Biophys (221) [1], Seite 281-290. [3] Steinberg, D. (1997): Low density lipoprotein oxidation and its pathobiological significance, J Biol Chem (272) [34], Seite 20963-20966. [4] Pryor, W.A. (2000): Vitamin E and heart disease: basic science to clinical intervention trials, Free Radic Biol Med (28) [1], Seite 141-164. [5] Stephens, N.G.; Parsons, A.; Schofield, P.M.; Kelly, F.; Cheeseman, K. und Mitchinson, M.J. (1996): Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS), Lancet (347) [9004], Seite 781-786. [6] Spector, R. und Vesell, E.S. (2002): Which studies of therapy merit credence? Vitamin E and estrogen therapy as cautionary examples, J Clin Pharmacol (42) [9], Seite 955-962. [7] Ricciarelli, R.; Tasinato, A.; Clement, S.; Ozer, N.K.; Boscoboinik, D. und Azzi, A. (1998): alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state, Biochem J (334 ( Pt 1)), Seite 243-249. [8] Kolleck, I.; Witt, W.; Wissel, H.; Sinha, P. und Rustow, B. (2000): HDL and vitamin E in plasma and the expression of SR-BI on lung cells during rat perinatal development, Lung (178) [4], Seite 191-200. [9] Boscoboinik, D.; Szewczyk, A.; Hensey, C. und Azzi, A. (1991): Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C, J Biol Chem (266) [10], Seite 6188-6194. [10] Szuwart, T.; Brzoska, T.; Luger, T.A.; Filler, T.; Peuker, E. und Dierichs, R. (2000): Vitamin E reduces platelet adhesion to human endothelial cells in vitro, Am J Hematol (65) [1], Seite 1-4. [11] Saldeen, T.; Li, D. und Mehta, J.L. (1999): Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis, J Am Coll Cardiol (34) [4], Seite 1208-1215. [12] Aratri, E.; Spycher, S.E.; Breyer, I. und Azzi, A. (1999): Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells, FEBS Lett (447) [1], Seite 91-94. [13] Ricciarelli, R.; Zingg, J.M. und Azzi, A. (2000): Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells, Circulation (102) [1], Seite 82-87. [14] Azzi, A.; Ricciarelli, R. und Zingg, J.M. (2002): Non-antioxidant molecular functions of alpha-tocopherol (vitamin E), FEBS Lett (519) [1-3], Seite 8-10. [15] Horwitt, M.K. (2001): Critique of the requirement for vitamin E, Am J Clin Nutr (73) [6], Seite 1003-1005. [16] Traber, M.G. und Sies, H. (1996): Vitamin E in humans: demand and delivery, Annu Rev Nutr (16), Seite 321-347. [17] Brigelius-Flohe, R. und Traber, M.G. (1999): Vitamin E: function and metabolism, FASEB J (13) [10], Seite 1145-1155. [18] Sattler, W. und Stocker, R. (1993): Greater selective uptake by Hep G2 cells of high-density lipoprotein cholesteryl ester hydroperoxides than of unoxidized cholesteryl esters, Biochem J (294 ( Pt 3)), Seite 771-778. [19] Traber, M.G. und Kayden, H.J. (1984): Vitamin E is delivered to cells via the high affinity receptor for low-density lipoprotein, Am J Clin Nutr (40) [4], Seite 747-751. [20] Goti, D.; Reicher, H.; Malle, E.; Kostner, G.M.; Panzenboeck, U. und Sattler, W. (1998): High-density lipoprotein (HDL3)-associated alpha-tocopherol is taken up by HepG2 cells via the selective uptake pathway and resecreted with endogenously synthesized apo-lipoprotein B-rich lipoprotein particles, Biochem J (332 ( Pt 1)), Seite 57-65. [21] Löffler, G. und Petrides, P. (1997): Biochemie und Pathobiochemie,

Berlin Heidelberg New York

. [22] Krieger, M. (1999): Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI, Annu Rev Biochem (68), Seite 523-558. [23] Simons, K. und Ikonen, E. (2000): How cells handle cholesterol, Science (290) [5497], Seite 1721-1726. [24] Fielding, C.J. und Fielding, P.E. (1995): Molecular physiology of reverse cholesterol transport, J Lipid Res (36) [2], Seite 211-228. [25] Pieters, M.N.; Schouten, D. und Van Berkel, T.J. (1994): In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport, Biochim Biophys Acta (1225) [2], Seite 125-134. [26] Krieger, M. (1998): The "best" of cholesterols, the "worst" of cholesterols: a tale of two receptors, Proc Natl Acad Sci U S A (95) [8], Seite 4077-4080. [27] Botham, K.M. und Bravo, E. (1995): The role of lipoprotein cholesterol in biliary steroid secretion. Studies with in vivo experimental models, Prog Lipid Res (34) [1], Seite 71-97. [28] Gwynne, J.T. und Strauss, J.F., 3rd (1982): The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands, Endocr Rev (3) [3], Seite 299-329. [29] Glass, C.; Pittman, R.C.; Weinstein, D.B. und Steinberg, D. (1983): Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad, Proc Natl Acad Sci U S A (80) [17], Seite 5435-5439. [30] Glomset, J.A. (1968): The plasma lecithins:cholesterol acyltransferase reaction, J Lipid Res (9) [2], Seite 155-167. [31] Gwynne, J.T. (1989): High-density lipoprotein cholesterol levels as a marker of reverse cholesterol transport, Am J Cardiol (64) [13], Seite 10G-17G. [32] Gwynne, J.T. und Mahaffee, D.D. (1989): Rat adrenal uptake and metabolism of high density lipoprotein cholesteryl ester, J Biol Chem (264) [14], Seite 8141-8150. [33] Oram, J.F. und Yokoyama, S. (1996): Apolipoprotein-mediated removal of cellular cholesterol and phospholipids, J Lipid Res (37) [12], Seite 2473-2491. [34] Brown, M.S. und Goldstein, J.L. (1999): A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood, Proc Natl Acad Sci U S A (96) [20], Seite 11041-11048. [35] Brown, M.S.; Ye, J.; Rawson, R.B. und Goldstein, J.L. (2000): Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans, Cell (100) [4], Seite 391-398. [36] Yokoyama, S. (2000): Release of cellular cholesterol: molecular mechanism for cholesterol homeostasis in cells and in the body, Biochim Biophys Acta (1529) [1-3], Seite 231-244. [37] Christian, A.E.; Haynes, M.P.; Phillips, M.C. und Rothblat, G.H. (1997): Use of cyclodextrins for manipulating cellular cholesterol content, J Lipid Res (38) [11], Seite 2264-2272. [38] Acton, S.; Rigotti, A.; Landschulz, K.T.; Xu, S.; Hobbs, H.H. und Krieger, M. (1996): Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, Science (271) [5248], Seite 518-520. [39] Acton, S.L.; Scherer, P.E.; Lodish, H.F. und Krieger, M. (1994): Expression cloning of SR-BI, a CD36-related class B scavenger receptor, J Biol Chem (269) [33], Seite 21003-21009. [40] Williams, D.L.; Connelly, M.A.; Temel, R.E.; Swarnakar, S.; Phillips, M.C.; de la Llera-Moya, M. und Rothblat, G.H. (1999): Scavenger receptor BI and cholesterol trafficking, Curr Opin Lipidol (10) [4], Seite 329-339. [41] Babitt, J.; Trigatti, B.; Rigotti, A.; Smart, E.J.; Anderson, R.G.; Xu, S. und Krieger, M. (1997): Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae, J Biol Chem (272) [20], Seite 13242-13249. [42] Lisanti, M.P.; Scherer, P.E.; Vidugiriene, J.; Tang, Z.; Hermanowski-Vosatka, A.; Tu, Y.H.; Cook, R.F. und Sargiacomo, M. (1994): Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease, J Cell Biol (126) [1], Seite 111-126. [43] Kurzchalia, T.V. und Parton, R.G. (1999): Membrane microdomains and caveolae, Curr Opin Cell Biol (11) [4], Seite 424-431. [44] Gwynne, J.T. und Hess, B. (1980): The role of high density lipoproteins in rat adrenal cholesterol metabolism and steroidogenesis, J Biol Chem (255) [22], Seite 10875-10883. [45] Pittman, R.C.; Knecht, T.P.; Rosenbaum, M.S. und Taylor, C.A., Jr (1987): A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters, J Biol Chem (262) [6], Seite 2443-2450. [46] Azhar, S.; Tsai, L. und Reaven, E. (1990): Uptake and utilization of lipoprotein cholesteryl esters by rat granulosa cells, Biochim Biophys Acta (1047) [2], Seite 148-160. [47] Reaven, E.; Chen, Y.D.; Spicher, M. und Azhar, S. (1984): Morphological evidence that high density lipoproteins are not internalized by steroid-producing cells during in situ organ perfusion, J Clin Invest (74) [4], Seite 1384-1397. [48] Rinninger, F. und Pittman, R.C. (1988): Regulation of the selective uptake of high density lipoprotein-associated cholesteryl esters by human fibroblasts and Hep G2 hepatoma cells, J Lipid Res (29) [9], Seite 1179-1194. [49] Rinninger, F.; Brundert, M.; Jackle, S.; Galle, P.R.; Busch, C.; Izbicki, J.R.; Rogiers, X.; Henne-Bruns, D.; Kremer, B. und Broelsch, C.E. (1994): Selective uptake of high-density lipoprotein-associated cholesteryl esters by human hepatocytes in primary culture, Hepatology (19) [5], Seite 1100-1114. [50] Azhar, S.; Tsai, L.; Medicherla, S.; Chandrasekher, Y.; Giudice, L. und Reaven, E. (1998): Human granulosa cells use high density lipoprotein cholesterol for steroidogenesis, J Clin Endocrinol Metab (83) [3], Seite 983-991. [51] Temel, R.E.; Trigatti, B.; DeMattos, R.B.; Azhar, S.; Krieger, M. und Williams, D.L. (1997): Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells, Proc Natl Acad Sci U S A (94) [25], Seite 13600-13605. [52] Rigotti, A.; Trigatti, B.L.; Penman, M.; Rayburn, H.; Herz, J. und Krieger, M. (1997): A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism, Proc Natl Acad Sci U S A (94) [23], Seite 12610-12615. [53] Ji, Y.; Jian, B.; Wang, N.; Sun, Y.; Moya, M.L.; Phillips, M.C.; Rothblat, G.H.; Swaney, J.B. und Tall, A.R. (1997): Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux, J Biol Chem (272) [34], Seite 20982-20985. [54] Jian, B.; de la Llera-Moya, M.; Ji, Y.; Wang, N.; Phillips, M.C.; Swaney, J.B.; Tall, A.R. und Rothblat, G.H. (1998): Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors, J Biol Chem (273) [10], Seite 5599-5606. [55] de la Llera-Moya, M.; Rothblat, G.H.; Connelly, M.A.; Kellner-Weibel, G.; Sakr, S.W.; Phillips, M.C. und Williams, D.L. (1999): Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface, J Lipid Res (40) [3], Seite 575-580. [56] Urban, S.; Zieseniss, S.; Werder, M.; Hauser, H.; Budzinski, R. und Engelmann, B. (2000): Scavenger receptor BI transfers major lipoprotein-associated phospholipids into the cells, J Biol Chem (275) [43], Seite 33409-33415. [57] Kolleck, I.; Schlame, M.; Fechner, H.; Looman, A.C.; Wissel, H. und Rustow, B. (1999): HDL is the major source of vitamin E for type II pneumocytes, Free Radic Biol Med (27) [7-8], Seite 882-890. [58] Goti, D.; Hrzenjak, A.; Levak-Frank, S.; Frank, S.; van der Westhuyzen, D.R.; Malle, E. und Sattler, W. (2001): Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E, J Neurochem (76) [2], Seite 498-508. [59] Green, S.R. und Pittman, R.C. (1991): Comparative acyl specificities for transfer and selective uptake of high density lipoprotein cholesteryl esters, J Lipid Res (32) [3], Seite 457-467. [60] Rigotti, A.; Miettinen, H.E. und Krieger, M. (2003): The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues, Endocr Rev (24) [3], Seite 357-387. [61] Kozarsky, K.F.; Donahee, M.H.; Rigotti, A.; Iqbal, S.N.; Edelman, E.R. und Krieger, M. (1997): Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels, Nature (387) [6631], Seite 414-417. [62] Ji, Y.; Wang, N.; Ramakrishnan, R.; Sehayek, E.; Huszar, D.; Breslow, J.L. und Tall, A.R. (1999): Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile, J Biol Chem (274) [47], Seite 33398-33402. [63] Sehayek, E.; Ono, J.G.; Shefer, S.; Nguyen, L.B.; Wang, N.; Batta, A.K.; Salen, G.; Smith, J.D.; Tall, A.R. und Breslow, J.L. (1998): Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption, Proc Natl Acad Sci U S A (95) [17], Seite 10194-10199. [64] Ueda, Y.; Royer, L.; Gong, E.; Zhang, J.; Cooper, P.N.; Francone, O. und Rubin, E.M. (1999): Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice, J Biol Chem (274) [11], Seite 7165-7171. [65] Wang, N.; Arai, T.; Ji, Y.; Rinninger, F. und Tall, A.R. (1998): Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice, J Biol Chem (273) [49], Seite 32920-32926. [66] Rigotti, A.; Trigatti, B.; Babitt, J.; Penman, M.; Xu, S. und Krieger, M. (1997): Scavenger receptor BI--a cell surface receptor for high density lipoprotein, Curr Opin Lipidol (8) [3], Seite 181-188. [67] Varban, M.L.; Rinninger, F.; Wang, N.; Fairchild-Huntress, V.; Dunmore, J.H.; Fang, Q.; Gosselin, M.L.; Dixon, K.L.; Deeds, J.D.; Acton, S.L.; Tall, A.R. und Huszar, D. (1998): Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol, Proc Natl Acad Sci U S A (95) [8], Seite 4619-4624. [68] Rigotti, A.; Edelman, E.R.; Seifert, P.; Iqbal, S.N.; DeMattos, R.B.; Temel, R.E.; Krieger, M. und Williams, D.L. (1996): Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland, J Biol Chem (271) [52], Seite 33545-33549. [69] Landschulz, K.T.; Pathak, R.K.; Rigotti, A.; Krieger, M. und Hobbs, H.H. (1996): Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat, J Clin Invest (98) [4], Seite 984-995. [70] Wang, N.; Weng, W.; Breslow, J.L. und Tall, A.R. (1996): Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control, J Biol Chem (271) [35], Seite 21001-21004. [71] Spady, D.K.; Woollett, L.A.; Meidell, R.S. und Hobbs, H.H. (1998): Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse, J Lipid Res (39) [7], Seite 1483-1492. [72] Fluiter, K.; van der Westhuijzen, D.R. und Van Berkel, T.J. (1998): In vivo regulation of scavenger receptor BI and the selective uptake of high density lipoprotein cholesteryl esters in rat liver parenchymal and Kupffer cells, J Biol Chem (273) [14], Seite 8434-8438. [73] Witt, W.; Kolleck, I.; Fechner, H.; Sinha, P. und Rustow, B. (2000): Regulation by vitamin E of the scavenger receptor BI in rat liver and HepG2 cells, J Lipid Res (41) [12], Seite 2009-2016. [74] Trigatti, B.; Rayburn, H.; Vinals, M.; Braun, A.; Miettinen, H.; Penman, M.; Hertz, M.; Schrenzel, M.; Amigo, L.; Rigotti, A. und Krieger, M. (1999): Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology, Proc Natl Acad Sci U S A (96) [16], Seite 9322-9327. [75] Miettinen, H.E.; Rayburn, H. und Krieger, M. (2001): Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice, J Clin Invest (108) [11], Seite 1717-1722. [76] Van Eck, M.; Twisk, J.; Hoekstra, M.; Van Rij, B.T.; Van der Lans, C.A.; Bos, I.S.; Kruijt, J.K.; Kuipers, F. und Van Berkel, T.J. (2003): Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver, J Biol Chem (278) [26], Seite 23699-23705. [77] Braun, A.; Trigatti, B.L.; Post, M.J.; Sato, K.; Simons, M.; Edelberg, J.M.; Rosenberg, R.D.; Schrenzel, M. und Krieger, M. (2002): Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice, Circ Res (90) [3], Seite 270-276. [78] Trigatti, B.L.; Krieger, M. und Rigotti, A. (2003): Influence of the HDL Receptor SR-BI on Lipoprotein Metabolism and Atherosclerosis, Arterioscler Thromb Vasc Biol (23) [10], Seite 1732-1738. [79] Purcell-Huynh, D.A.; Farese, R.V., Jr; Johnson, D.F.; Flynn, L.M.; Pierotti, V.; Newland, D.L.; Linton, M.F.; Sanan, D.A. und Young, S.G. (1995): Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet, J Clin Invest (95) [5], Seite 2246-2257. [80] Arai, T.; Wang, N.; Bezouevski, M.; Welch, C. und Tall, A.R. (1999): Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene, J Biol Chem (274) [4], Seite 2366-2371. [81] Kozarsky, K.F.; Donahee, M.H.; Glick, J.M.; Krieger, M. und Rader, D.J. (2000): Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse, Arterioscler Thromb Vasc Biol (20) [3], Seite 721-727. [82] Ueda, Y.; Gong, E.; Royer, L.; Cooper, P.N.; Francone, O.L. und Rubin, E.M. (2000): Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics, J Biol Chem (275) [27], Seite 20368-20373. [83] Pratico, D.; Tangirala, R.K.; Rader, D.J.; Rokach, J. und FitzGerald, G.A. (1998): Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice, Nat Med (4) [10], Seite 1189-1192. [84] Thomas, S.R.; Leichtweis, S.B.; Pettersson, K.; Croft, K.D.; Mori, T.A.; Brown, A.J. und Stocker, R. (2001): Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice, Arterioscler Thromb Vasc Biol (21) [4], Seite 585-593. [85] Kosters, A.; Jirsa, M. und Groen, A.K. (2003): Genetic background of cholesterol gallstone disease, Biochim Biophys Acta (1637) [1], Seite 1-19. [86] Fuchs, M.; Ivandic, B.; Muller, O.; Schalla, C.; Scheibner, J.; Bartsch, P. und Stange, E.F. (2001): Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI, Hepatology (33) [6], Seite 1451-1459. [87] Rigotti, A.; Zanlungo, S.; Miquel, J.F. und Wang, D.Q. (2002): HDL receptor SR-BI and cholesterol gallstones, Hepatology (35) [1], Seite 240-242. [88] Rodrigueza, W.V.; Thuahnai, S.T.; Temel, R.E.; Lund-Katz, S.; Phillips, M.C. und Williams, D.L. (1999): Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells, J Biol Chem (274) [29], Seite 20344-20350. [89] Greene, D.J.; Skeggs, J.W. und Morton, R.E. (2001): Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor class B type I (SR-BI), J Biol Chem (276) [7], Seite 4804-4811. [90] Chapman, M.J.; Goldstein, S.; Lagrange, D. und Laplaud, P.M. (1981): A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum, J Lipid Res (22) [2], Seite 339-358. [91] Walker, J.M. (1994): The bicinchoninic acid (BCA) assay for protein quantitation, Methods Mol Biol (32), Seite 5-8. [92] Catignani, G.L. und Bieri, J.G. (1983): Simultaneous determination of retinol and a-tocopherol in serum or plasma by liquid chromatography, Clin Chem (29), Seite 708-712. [93] Gobran, L.I. und Rooney, S.A. (1998): PKC isoforms and other signaling proteins involved in surfactant secretion in developing rat type II cells, Am J Physiol (274) [6 Pt 1], Seite 901-907. [94] Gobran, L.I. und Rooney, S.A. (1999): Surfactant secretagogue activation of protein kinase c isoforms in cultured rat type II cells, Am J Physiol (277) [2 Pt 1], Seite 251-256. [95] Laemmli, U.K. (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature (227) [259], Seite 680-685. [96] Schrimpf, G. und Gassen, R. (1999): Gentechnische Methoden. [97] Burnette, W.N. (1981): "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A, Anal Biochem (112) [2], Seite 195-203. [98] Salinovich, O. und Montelaro, R.C. (1986): Reversible staining and peptide mapping of proteins transferred to nitrocellulose after separation by sodium dodecylsulfate-polyacrylamide gel electrophoresis, Anal Biochem (156) [2], Seite 341-347. [99] Sinha, P.; Kolleck, I.; Volk, H.D.; Schlame, M. und Rustow, B. (2002): Vitamin E deficiency sensitizes alveolar type II cells for apoptosis, Biochim Biophys Acta (1583) [1], Seite 91-98. [100] Tolle, A.; Kolleck, I.; Schlame, M.; Wauer, R.; Stevens, P.A. und Rustow, B. (1997): Effect of hyperoxia on the composition of the alveolar surfactant and the turnover of surfactant phospholipids, cholesterol, plasmalogens and vitamin E, Biochim Biophys Acta (1346) [2], Seite 198-204. [101] Mardones, P.; Quinones, V.; Amigo, L.; Moreno, M.; Miquel, J.F.; Schwarz, M.; Miettinen, H.E.; Trigatti, B.; Krieger, M.; VanPatten, S.; Cohen, D.E. und Rigotti, A. (2001): Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice, J Lipid Res (42) [2], Seite 170-180. [102] Mardones, P.; Strobel, P.; Miranda, S.; Leighton, F.; Quinones, V.; Amigo, L.; Rozowski, J.; Krieger, M. und Rigotti, A. (2002): Alpha-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice, J Nutr (132) [3], Seite 443-449. [103] Johnson, W.J.; Bamberger, M.J.; Latta, R.A.; Rapp, P.E.; Phillips, M.C. und Rothblat, G.H. (1986): The bidirectional flux of cholesterol between cells and lipoproteins. Effects of phospholipid depletion of high density lipoprotein, J Biol Chem (261) [13], Seite 5766-5776. [104] Rothblat, G.H.; de la Llera-Moya, M.; Atger, V.; Kellner-Weibel, G.; Williams, D.L. und Phillips, M.C. (1999): Cell cholesterol efflux: integration of old and new observations provides new insights, J Lipid Res (40) [5], Seite 781-796. [105] Gu, X.; Kozarsky, K. und Krieger, M. (2000): Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor, J Biol Chem (275) [39], Seite 29993-30001. [106] Yancey, P.G.; Bortnick, A.E.; Kellner-Weibel, G.; de la Llera-Moya, M.; Phillips, M.C. und Rothblat, G.H. (2003): Importance of Different Pathways of Cellular Cholesterol Efflux, Arterioscler Thromb Vasc Biol EDAT- // : MHDA- // : PHST- /Jan/ [aheadofprint] AID - ./.ATV...DD [doi] AID - .ATV...DD [pii] PST - ppublish (23) [5], Seite 712-719. [107] Kellner-Weibel, G.; de la Llera-Moya, M.; Connelly, M.A.; Stoudt, G.; Christian, A.E.; Haynes, M.P.; Williams, D.L. und Rothblat, G.H. (2000): Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution, Biochemistry (39) [1], Seite 221-229. [108] Langer, C.; Gansz, B.; Goepfert, C.; Engel, T.; Uehara, Y.; von Dehn, G.; Jansen, H.; Assmann, G. und von Eckardstein, A. (2002): Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages, Biochem Biophys Res Commun (296) [5], Seite 1051-1057. [109] Fielding, C.J. und Fielding, P.E. (2001): Cellular cholesterol efflux, Biochim Biophys Acta (1533) [3], Seite 175-189. [110] Bortnick, A.E.; Rothblat, G.H.; Stoudt, G.; Hoppe, K.L.; Royer, L.J.; McNeish, J. und Francone, O.L. (2000): The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines, J Biol Chem (275) [37], Seite 28634-28640. [111] Liscovitch, M. und Lavie, Y. (2000): Multidrug resistance: a role for cholesterol efflux pathways?, Trends Biochem Sci (25) [11], Seite 530-534. [112] Gillotte, K.L.; Zaiou, M.; Lund-Katz, S.; Anantharamaiah, G.M.; Holvoet, P.; Dhoest, A.; Palgunachari, M.N.; Segrest, J.P.; Weisgraber, K.H.; Rothblat, G.H. und Phillips, M.C. (1999): Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid, J Biol Chem (274) [4], Seite 2021-2028. [113] Gillotte, K.L.; Davidson, W.S.; Lund-Katz, S.; Rothblat, G.H. und Phillips, M.C. (1998): Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization, J Lipid Res (39) [10], Seite 1918-1928. [114] Wang, L.; Connelly, M.A.; Ostermeyer, A.G.; Chen, H.H.; Williams, D.L. und Brown, D.A. (2003): Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines, J Lipid Res (44) [4], Seite 807-815. [115] Sun, Y.; Wang, N. und Tall, A.R. (1999): Regulation of adrenal scavenger receptor-BI expression by ACTH and cellular cholesterol pools, J Lipid Res (40) [10], Seite 1799-1805. [116] Azhar, S.; Nomoto, A.; Leers-Sucheta, S. und Reaven, E. (1998): Simultaneous induction of an HDL receptor protein (SR-BI) and the selective uptake of HDL-cholesteryl esters in a physiologically relevant steroidogenic cell model, J Lipid Res (39) [8], Seite 1616-1628. [117] Rothblat, G.H.; de la Llera-Moya, M.; Favari, E.; Yancey, P.G. und Kellner-Weibel, G. (2002): Cellular cholesterol flux studies: methodological considerations, Atherosclerosis (163) [1], Seite 1-8. [118] Knowles, B.B.; Howe, C.C. und Aden, D.P. (1980): Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen, Science (209) [4455], Seite 497-499. [119] Rash, J.M.; Rothblat, G.H. und Sparks, C.E. (1981): Lipoprotein apolipoprotein synthesis by human hepatoma cells in culture, Biochim Biophys Acta (666) [2], Seite 294-298.